{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:05:09Z","timestamp":1759017909501,"version":"3.44.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:00:00Z","timestamp":1697068800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007217","name":"Health Services Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007217","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006379","name":"Office of Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006379","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.clinthera.2023.10.009","type":"journal-article","created":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T15:13:26Z","timestamp":1699715606000},"page":"40-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Combination Therapy Use and Associated Events in Clinical Practice Following Dissemination of Trial Findings: A De-Implementation Study Using Interrupted Time Series Analysis"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6401-9240","authenticated-orcid":false,"given":"Heather M.","family":"Campbell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison E.","family":"Murata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam M.","family":"Henrie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd A.","family":"Conner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2023.10.009_bib0001","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1592\/phco.2005.25.11.1602","article-title":"Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus","volume":"25","author":"Hughes","year":"2005","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0002","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1111\/j.1523-1755.2004.00653.x","article-title":"Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL","volume":"65","author":"de Zeeuw","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0003","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1053\/j.ajkd.2004.10.019","article-title":"Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy","volume":"45","author":"Atkins","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0004","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1136\/bmj.321.7274.1440","article-title":"Randomized controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril in microalbuminuria (CALM) study","volume":"321","author":"Mogensen","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2023.10.009_bib57","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s592-001-8073-2","article-title":"Efficacy of ACE inhibitors and ATII receptor blockers in patients with microalbuminuria: a prospective study","volume":"38","author":"Tutuncu","year":"2001","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.clinthera.2023.10.009_bib58","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.diabres.2005.06.010","article-title":"Beneficial effect of lisinopril plus telmisartan in patients with type 2 diabetes, microalbuminuria and hypertension","volume":"71","author":"Sengul","year":"2006","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.clinthera.2023.10.009_bib59","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1368-5031.2004.00004.x","article-title":"Anti-proteinuric effects of combination therapy with enalapril and losartan in patients with nephropathy due to type 2 diabetes","volume":"58","author":"Cetinkaya","year":"2004","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.clinthera.2023.10.009_bib60","doi-asserted-by":"crossref","first-page":"180","DOI":"10.5414\/CNP64180","article-title":"Effects of dual blockade of the renin angiotensin system in hypertensive type 2 diabetic patients with nephropathy","volume":"64","author":"Matos","year":"2005","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.clinthera.2023.10.009_bib61","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/ndt\/gfi310","article-title":"Effect of low-dose dual blockade of renin-angiotensin system on urinary TGF-beta in type 2 diabetic patients with advanced kidney disease","volume":"21","author":"Song","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clinthera.2023.10.009_bib62","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.amjhyper.2004.08.001","article-title":"Combination of half doses of angiotensin type 1 receptor antagonist and angiotensin-converting enzyme inhibitor in diabetic nephropathy","volume":"18","author":"Fujisawa","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.clinthera.2023.10.009_bib63","doi-asserted-by":"crossref","first-page":"318","DOI":"10.5414\/CNP60318","article-title":"The effects of dual blockade of the renin-angiotensin system on urinary protein and transforming growth factor-beta excretion in 2 groups of patients with IgA and diabetic nephropathy","volume":"60","author":"Song","year":"2003","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.clinthera.2023.10.009_bib64","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2337\/diacare.25.1.95","article-title":"Dual blockade of the renin-angiotensin system in diabetic nephropathy: a randomized double-blind crossover study","volume":"25","author":"Rossing","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2023.10.009_bib65","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.2337\/diacare.26.8.2268","article-title":"Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: a randomized double-blind crossover trial","volume":"26","author":"Rossing","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2023.10.009_bib66","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1291\/hypres.25.849","article-title":"Antiproteinuric effects of combined antihypertensive therapies in patients with overt type 2 diabetic nephropathy","volume":"25","author":"Kuriyama","year":"2002","journal-title":"Hypertens Res"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0005","doi-asserted-by":"crossref","first-page":"32","DOI":"10.15420\/usc.2006.3.2.32","article-title":"Angiotensin-receptor blocker therapy-chronic kidney disease and diabetes","volume":"3","author":"Sica","year":"2006","journal-title":"US Cardiology"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0006","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1056\/NEJMoa1303154","article-title":"Combined angiotensin inhibition for the treatment of diabetic nephropathy","volume":"369","author":"Fried","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0007","series-title":"Pathophysiology of Disease: An Introduction to Clinical Medicine","article-title":"Disorders of the endocrine pancreas","author":"Funk","year":"2014"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0008","first-page":"14S","article-title":"Federal health care data trends 2016. Diabetes and obesity","volume":"33","year":"2016","journal-title":"Fed Pract"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0009","doi-asserted-by":"crossref","DOI":"10.1136\/qshc.2003.009506","article-title":"Unlearning in health care","author":"Rushmer","year":"2004","journal-title":"Qual Saf Health Care"},{"year":"2008","series-title":"National PBM Drug Safety Alert Distribution","key":"10.1016\/j.clinthera.2023.10.009_bib0010"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0011","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13012-015-0209-1","article-title":"A refined compilation of implementation strategies: results from the Expert Recommendations for Implementing Change","volume":"10","author":"Powell","year":"2015","journal-title":"Implement Sci"},{"key":"10.1016\/j.clinthera.2023.10.009_bib67","unstructured":"Palevsky PM, Zhang JH, Seliger SL, Emanuele N, Fried LF. Acute Kidney Injury (AKI) Associated with Combined Antiotensin Antagonism in Patients with Diabetic Nephropathy - A Secondary Analysis. Kidney Week 2013-JASN Abstract Supplement, p. 1066. Available at: asn-online.org\/education\/kidneyweek\/archives\/KW13Abstracts.pdf. Accessed on 11\/2\/2023."},{"first-page":"1","year":"2014","series-title":"VA\/DoD Clinical Practice Guideline for the Management of Chronic Kidney Disease in Primary Care, Version 3.0-2014","key":"10.1016\/j.clinthera.2023.10.009_bib68"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0012","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13012-019-0960-9","article-title":"Unpacking the complexities of de-implementing inappropriate health interventions","volume":"15","author":"Norton","year":"2020","journal-title":"Implement Sci"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0013","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/intqhc\/mzy100","article-title":"Limit, lean, or listen? A typology of low-value care that dives direction to de-implementation","volume":"30","author":"Verkerk","year":"2018","journal-title":"Int J Qual Health Care"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0014","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/1740774518813121","article-title":"Automated safety event monitoring using electronic medical records in a clinical trial setting: validation study using the VA NEPHRON-D trial","volume":"16","author":"Huang","year":"2019","journal-title":"Clin Trials"},{"year":"1979","series-title":"Quasi-experimentation: Design and analysis issues for field setting","author":"Cook","key":"10.1016\/j.clinthera.2023.10.009_bib0015"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0016","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1365-2710.2002.00430.x","article-title":"Segmented regression analysis of interrupted time series studies in medication use research","volume":"27","author":"Wagner","year":"2002","journal-title":"J Clin Phar Ther"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0017","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2105\/AJPH.71.1.38","article-title":"Analysis of interrupted time series mortality trends: an example to evaluation regionalized perinatal care","volume":"71","author":"Gillings","year":"1981","journal-title":"Am J Public Health"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0018","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1037\/0893-3200.21.4.726","article-title":"Rethinking how family researchers model infrequent outcomes: a tutorial on count regression and zero-inflated models","volume":"21","author":"Atkins","year":"2007","journal-title":"J Fam Psychol"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0019","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.jclinepi.2014.12.018","article-title":"Interrupted time series analysis in drug utilization research is increasing: systematic review and recommendations","volume":"68","author":"Jandoc","year":"2015","journal-title":"J Clin Epi"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0020","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-013318","article-title":"Standards for reporting implementation studies: explanation and elaboration document","volume":"7","author":"Pinnock","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0021","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.clpt.2005.12.304","article-title":"A therapeutic substitution policy for proton pump inhibitors: clinical and economic consequences","volume":"79","author":"Schneeweiss","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0022","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"Yusuf","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0023","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(08)61236-2","article-title":"Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicenter, double-blind, controlled trial","volume":"372","author":"Mann","year":"2008","journal-title":"Lancet"},{"year":"2001","series-title":"Crossing the Quality Chasm: a New Health System for the 21st Century","key":"10.1016\/j.clinthera.2023.10.009_bib0024"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0025","first-page":"167","article-title":"Accelerating the use of best practice: The Mayo Clinic model of diffusion","volume":"39","author":"Dilling","year":"2013","journal-title":"Jt Comm J Qual Saf"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0026","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13012-014-0162-4","article-title":"Spreading and sustaining best practices for home care of older adults: a grounded theory study","volume":"9","author":"Ploeg","year":"2014","journal-title":"Implement Sci"},{"year":"2014","series-title":"VA Pharmacy Benefits Management Services, Medical Advisory Panel, and VISN Pharmacist Executives Angiotensin II Receptor Antagonists: Recommendations for Use, Update February 2014","key":"10.1016\/j.clinthera.2023.10.009_bib0027"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0028","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13012-022-01238-z","article-title":"Randomized controlled trials in de-implementation research: a systematic scoping review","volume":"17","author":"Raudasoja","year":"2022","journal-title":"Implement Sci"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0029","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13012-018-0732-y","article-title":"Reduction of antibiotic prescriptions for acute respiratory tract infections in primary care: a systematic review","volume":"13","author":"Kochling","year":"2018","journal-title":"Implement Sci"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0030","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1177\/1077558716656970","article-title":"Interventions aimed at reducing use of low-value health care services: a systematic review","volume":"74","author":"Colla","year":"2017","journal-title":"Med Care Res Rev"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0031","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13012-022-01247-y","article-title":"Strategies for de-implementation of low-value care- a scoping review","volume":"17","author":"Ingvarsson","year":"2022","journal-title":"Implement Sci"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0032","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1748-5908-7-50","article-title":"Knowledge translation of research findings","volume":"7","author":"Grimshaw","year":"2012","journal-title":"Implement Sci"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0033","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/1468-0009.12531","article-title":"The impact of choosing wisely interventions on low-value medical services: a systematic review","volume":"99","author":"Cliff","year":"2021","journal-title":"Milbank Q"},{"key":"10.1016\/j.clinthera.2023.10.009_bib56","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13012-022-01247-y","article-title":"Strategies for de-implementation of low-value care-a scoping review","volume":"17","author":"Hasson","year":"2022","journal-title":"Implement Sci"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0034","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1056\/NEJM198306163082406","article-title":"Improving drug-therapy decisions through educational outreach: a randomized controlled trial of academically based \u201cdetailing\u201d","volume":"308","author":"Avorn","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0035","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1001\/jama.1983.03340130046031","article-title":"Improving antibiotic prescribing in office practice: a controlled trial of three educational methods","volume":"250","author":"Schaffner","year":"1983","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0036","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1046\/j.1525-1497.2001.016006351.x","article-title":"Influence of physician specialty on adoption and relinquishment of calcium channel blockers and other treatments for myocardial infarction","volume":"16","author":"Majumdar","year":"2001","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0037","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1001\/jama.291.1.54","article-title":"Impact of clinical trial results on national trends in \u03b1-blocker prescribing, 1996-2002","volume":"291","author":"Stafford","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0038","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1001\/jama.292.16.1983","article-title":"Promotion and prescribing of hormone therapy after report of harm by the Women's Health Initiative","volume":"292","author":"Majumdar","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0039","doi-asserted-by":"crossref","first-page":"184","DOI":"10.7326\/0003-4819-140-3-200402030-00009","article-title":"Changes in the use of postmenopausal hormone therapy after publication of clinical trial results","volume":"140","author":"Haas","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0040","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.291.1.47","article-title":"National use of postmenopausal hormone therapy: annual trends and response to recent evidence","volume":"291","author":"Hersh","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0041","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1089\/jwh.2009.1441","article-title":"Long-term effect of the women's health initiative study on antiosteoporosis medication prescribing","volume":"19","author":"Lee","year":"2010","journal-title":"J Womens Health"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0042","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1067\/mhj.2001.115587","article-title":"Randomized clinical trials and recent patterns in the use of statins","volume":"141","author":"Wang","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0043","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1345\/aph.1L211","article-title":"Comparison of the impact of the atrial fibrillation follow-up investigation of rhythm management trial on prescribing patterns: a time-series analysis","volume":"42","author":"Choudhry","year":"2008","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0044","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.schres.2012.01.043","article-title":"Impact of the CATIE trial on antipsychotic prescribing patterns at a state psychiatric facility","volume":"137","author":"Koranek","year":"2012","journal-title":"Schizophr Res"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0045","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1097\/00007632-199712150-00019","article-title":"Early physician notification of patient disability risk and clinical guidelines after low back injury: a randomized, controlled trial","volume":"22","author":"Hazard","year":"1997","journal-title":"Spine"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0046","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1001\/jama.1986.03370040075027","article-title":"Does a mailed continuing education program improve physician performance? Results of a randomized trial in antihypertensive care","volume":"255","author":"Evans","year":"1986","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0047","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1472-6963-7-79","article-title":"Implementing a guideline for the treatment of type 2 diabetics: results of a cluster-randomized controlled trial (C-RCT)","volume":"7","author":"Perria","year":"2007","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0048","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001588","article-title":"Effect of an educational toolkit on quality of care: a pragmatic cluster randomized trial","volume":"11","author":"Shah","year":"2014","journal-title":"PLoS Med"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0049","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1001\/jama.1989.03420140103035","article-title":"A randomized trial to increase smoking intervention by physicians. Doctors helping smokers, round I","volume":"261","author":"Kottke","year":"1989","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0050","first-page":"37","article-title":"Effectiveness of an educational strategy to improve family physicians\u2019 detection and management of depression","volume":"161","author":"Worrall","year":"1989","journal-title":"CMAJ"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0051","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1365-2753.2008.00978.x","article-title":"Cluster randomized clinical trial (ISRCTN23732000) to evaluate the effectiveness of a diagnosis recognition and treatment guide for depressive disorder in primary care","author":"Tsuji","year":"2009","journal-title":"J Eval Clin Pract"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0052","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.2337\/diacare.28.12.2942","article-title":"Lack of effect of guideline changes on LDL cholesterol reporting and control for diabetes visits in the U.S., 1995-2004","volume":"28","author":"Wang","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0053","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1016\/S0140-6736(12)60480-2","article-title":"Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis","volume":"379","author":"Tricco","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2023.10.009_bib69","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"NEJM"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0054","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJMoa040135","article-title":"Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study","volume":"351","author":"Juurlink","year":"2004","journal-title":"NEJM"},{"key":"10.1016\/j.clinthera.2023.10.009_bib0055","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1748-5908-8-139","article-title":"Implementation strategies: recommendations for specifying and reporting","volume":"8","author":"Proctor","year":"2013","journal-title":"Implement Sci"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291823004010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291823004010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:59:42Z","timestamp":1758963582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291823004010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0149291823004010"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2023.10.009","relation":{},"ISSN":["0149-2918"],"issn-type":[{"type":"print","value":"0149-2918"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination Therapy Use and Associated Events in Clinical Practice Following Dissemination of Trial Findings: A De-Implementation Study Using Interrupted Time Series Analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2023.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}